(The FASEB Journal. 2001;15:525-534.)
© 2001 FASEB
Prolonged hypoxia during cell development protects mature manganese superoxide dismutase-deficient astrocytes from damage by oxidative stress
JEAN-CHRISTOPHE COPIN*,
,
YVAN GASCHE*,
YIBING LI
and
PAK H. CHAN*,
1
* Department of Neurosurgery, Department of Neurology and Neurological Sciences, and Program in Neurosciences, Stanford University School of Medicine, Stanford, California 94305-5487 USA; and
Department of Neurological Surgery, University of California, School of Medicine, San Francisco, California 94143, USA
1Correspondence: Neurosurgical Labs, Stanford University, 1201 Welch Rd., MSLS P304, Stanford, CA 94305-5487 USA. E-mail: phchan{at}leland.stanford.edu
 |
ABSTRACT
|
|---|
Mouse astrocytes deficient in the mitochondrial form of superoxide
dismutase do not grow in culture under 20% atmospheric O2
levels. By flow cytometry, immunocytochemistry, and enzymatic analysis
we have shown that the oxygen block of cell division is due to a
decrease in the number of cells entering the S phase of the cell cycle
and is concomitant with higher DNA oxidation and impairment of
mitochondrial functions. Seeding the cells under 5% O2
until the cultures become confluent can circumvent this problem. An
initial hypoxic environment increases the resistance of manganese
superoxide dismutase-deficient astrocytes to superoxide radicals
artificially produced by paraquat treatment, preserves respiratory
activity, and allows normoxic division during a subsequent passage. DNA
oxidation is then not higher than in wild-type control cells. However,
the adaptation of the cells is not due to compensation by other enzymes
of the antioxidant defense system and is specific to cells totally
lacking manganese superoxide dismutase. Alteration of the phenotype by
prior hypoxia exposure in the SOD2-deficient mutant provide a unique
model to study adaptative mechanisms of cellular resistance to oxygen
toxicity.Copin, J.-C., Gasche, Y., Li, Y., Chan, P. H. Prolonged
hypoxia during cell development protects mature manganese superoxide
dismutase-deficient astrocytes from damage by oxidative stress.
Key Words: paraquat 8-oxo-7.8-dihydro-2'-deoxyguanosine mitochondria adaptation preconditioning
 |
INTRODUCTION
|
|---|
AEROBIC ORGANISMS DEPEND on oxygen availability to
generate their energy. Most of the oxygen molecules entering cells are
tetravalently reduced to water during oxidative phosphorylation of
adenosine diphosphate to adenosine triphosphate. However, 2 to 4% of
the oxygen consumed by the cells is univalently reduced to superoxide
radicals as a result of the leakage of electron transfer
(1)
. Superoxide radicals can be further reduced to
hydrogen peroxide and hydroxyl radicals through reactions catalyzed by
divalent metals or can react with nitric oxide to form peroxynitrites,
which in turn generate hydroxyl radicals (2
, 3)
.
Superoxide radicals, hydrogen peroxide, hydroxyl radicals, and
peroxynitrites, referred to as reactive oxygen species (ROS), are toxic
when generated in excess in cells. They can affect various molecular
components of the cells, damage DNA, inactivate enzymes, reduce the
efficiency of the transcriptional machinery and peroxidize
polyunsaturated lipids (4
5
6
7)
. On the other hand, a low
generation of ROS is responsible for the regulation of transcription
factors such as AP-1 and NF-
B, which in turn regulate many effector
genes (8)
. ROS may also influence the genetic control of
cell proliferation, and have been described as novel intra- and
intercellular messengers (9)
.
The reduction/oxidation state of cells is tightly regulated by an
antioxidant defense system, which is constituted of diverse enzymes and
free radical scavengers (10)
. The first line of defense
involves superoxide dismutases (SODs), which dismute superoxide into
hydrogen peroxide. Copper/zinc SOD (CuZnSOD) is located in the
cytoplasmic and nuclear compartments whereas manganese SOD (MnSOD) is
found inside the mitochondria. Hydrogen peroxide is converted to water
by catalase or glutathione peroxidase. The latter oxidizes glutathione,
which is recycled by a glutathione reductase that uses reduced
nicotinamide adenine dinucleotide phosphate (NADPH) as a cosubstrate.
Free radical scavengers can be hydrophilic, such as ascorbate, urate
and glutathione, or lipophilic such as tocopherols, flavonoids, and
ubiquinol. Moreover, a cellular machinery, which maintains a reducing
environment, is associated with the antioxidant defense system (e.g.,
glucose-6-phosphate dehydrogenase, which regenerates NADPH).
Variations in ambient oxygen concentration strongly modulate the
developmental fate of embryonic tissues as well as the rate of cell
growth in vitro, in both vertebrate and invertebrate
species. Saccharomyces cerevisiae deficient in MnSOD is
hypersensitive to oxygen, and increasing concentrations of oxygen lead
to a progressive inhibition of growth (11)
. In contrast,
MnSOD-deficient yeast with complete absence of electron transport grows
normally in hyperoxia, suggesting a role for superoxide radicals in
growth arrest (12)
. Exposure of bovine endothelial and
smooth muscle cells to hyperoxia delays the entry of the cells into the
S phase of the cell cycle and blocks the cells in the S and
G2 phases (13)
. Embryos generated by
in vitro fertilization and exposed to 20%
O2 instead of the relatively low
O2 tension present in the oviducal and uterine
environments become retarded or arrested in culture in vitro
(14)
. The in vitro block phenomenon of embryo
development is related to ROS generation. It can be bypassed by
performing cultures under 5% O2 conditions and
may be partially explained by oxidation of the thiol group of proteins
(15
, 16)
.
Genetically modified animals with alterations in the antioxidant
defense system are valuable tools for studying the effect of oxygen on
cellular functions in vivo and in vitro. Two
MnSOD-deficient mouse models have been produced by homologous
recombination techniques (17
, 18)
. Only heterozygous MnSOD
knockout animals (Sod2-/+) are viable, whereas homozygous
animals (Sod2-/-) die shortly after birth. Studies
performed on heterozygous animals demonstrate that an increase in
mitochondrial ROS can result in biochemical alterations with features
reminiscent of genetic mitochondrial disorders (19)
.
Altered mitochondrial functions in Sod2-/+ mice contrast
with the absence of change in oxidation of cytosolic proteins or
nuclear DNA (20)
. Permanent focal cerebral ischemia
performed on Sod2-/+ animals leads to a bigger infarct size
and higher neurological deficits in vivo, whereas glutamate
toxicity is exacerbated in Sod2-/+ cortical neurons
in vitro (21
, 22)
. However, some results
suggest that in mice only 50% of MnSOD activity may be sufficient for
normal resistance to 100% oxygen toxicity (23)
.
Sensitivity of MnSOD homozygous knockout cells to oxygen toxicity
depends on the type of cells that are cultured. Neuronal cultures of
Sod2-/- mice do not survive under normoxia
(22)
. Cultivation of Sod2-/- fetal
fibroblasts is possible and their growth is
60% that of wild-type
cells (24)
. In this study, we show that
Sod2-/- growing astrocytes are highly sensitive to 20%
oxygen in culture. Cultures of cerebral cells deficient in MnSOD are
valuable models to study the critical role played by MnSOD under normal
physiological conditions, as well as to better understand the
consequences of mitochondrial oxidative imbalance in pathophysiological
pathways such as excitotoxicity, hypoxia/reperfusion or apoptosis.
Thus, we cultured Sod2-/- astrocytes under 5%
O2. Our results indicate that MnSOD is necessary
for the normoxic development of primary astrocytes in vitro
by preventing mitochondrial injury, but is less necessary when the
cells reach confluency. Furthermore, during secondary culture,
Sod2-/- astrocytes do not have to be kept under 5%
O2 for successful dividing. They also become less
sensitive to paraquat treatment. The results are explained in light of
a possible adaptation of the cells and prompt further studies, which
may give new insight into the role of oxygen in gene regulation and the
effect of low oxygenation on phenomenon such as preconditioning.
 |
MATERIALS AND METHODS
|
|---|
MnSOD-deficient mice
The animals used in this study were mutated with a replacement
type targeting vector that inactivated the MnSOD gene (18)
and were extensively bred on a CD-1 background. Homozygous MnSOD
knockout animals were produced by crossing together heterozygous mice.
Immediately after birth, the animals were typed by polymerase chain
reaction amplification of mutant and normal fragments of the MnSOD gene
from tail DNA obtained by proteinase K digestion as described
previously (22)
.
Primary culture of astrocytes
Astrocytes were cultured as described by Juurlink and Hertz
(25)
with minor modifications. Briefly, cortical tissues
of newborn mice were dissociated by mechanical action and passed
sequentially through 80-µm and then 10-µm filtration meshes. Cell
suspensions in minimum essential medium (MEM, Gibco BRL, Grand Island,
N.Y.) supplemented with 20% fetal bovine serum (Gemini Bio-Products
Inc., Calabasas, Calif.) were plated into 24 multi-well plates, 35 mm
or 60 mm dishes (Falcon; Becton Dickinson, Franklin Lakes, N.J.), at a
dilution of one brain per 48 cm2 and incubated at
37°C under 5% CO2-air atmosphere in a
water-jacketed incubator (Forma Scientific Inc., Marietta, Ohio) or
under 5% O2-5% CO2-90%
N2 in a gas-tight humidified chamber (modular
incubator chamber; Billups-Rothenberg, Del Mar, Calif.). After 4 days
the culture medium was replaced with fresh MEM containing 10% fetal
bovine serum, and the astrocytes were fed twice a week.
Enzymatic activities
For enzymatic assays, astrocytes were cultured in 60 mm dishes.
SOD, catalase, glutathione peroxidase, and intracellular lactate
dehydrogenase (LDH) activity was measured in the supernatant obtained
after sonication of the cells and centrifugation at 20,800 g
for 15 min at 5°C. Total SOD and MnSOD activity, which was determined
after 30 min inactivation of CuZnSOD with 2 mM KCN, was measured by the
method of Crapo et al. (26)
. One unit of SOD was defined
as the quantity of enzyme necessary to inhibit by 50% the rate of
reduction of ferricytochrome c. Catalase activity was
measured by the method of Lück (27)
. One unit of
catalase was defined as the quantity of enzyme necessary to consume
half of the hydrogen peroxide in the reactive buffer in 1 min.
Glutathione peroxidase activity was measured by the method of Paglia
and Valentine (28)
. LDH activity present inside the cells
or released into the culture medium was measured spectrophotometrically
at 340 nm by following the rate of reduction of NAD in the presence of
lactate with a kit from Sigma (LD-L; Sigma, St. Louis, Mo.).
Superoxide radical generation
Intracellular production of superoxide radicals was achieved by
treatment of the cells for 15 h with doses of paraquat (Sigma)
ranging from 2.5 to 100 mM. Paraquat was directly dissolved in MEM,
which was used as a replacement medium for the cultures at the
beginning of the experiment. Cellular toxicity was measured by LDH
release into the medium and expressed as a percent of maximum release
that was obtained for a dose of 100 mM of paraquat.
Mitochondrial activity
The rate of respiration was measured with MTT
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) as an
alternative electron acceptor, according to the method described by
Manthorpe et al. (29)
. Results were normalized with the
protein content.
Protein and DNA contents
For developmental study, astrocytes were cultured in 24
multi-well plates. After washing, the cells were resuspended in 300
µl of water per well and sonicated. Protein concentration was
determined spectrophotometrically by the bicinchoninic method (BCA
Protein Assay Reagent kit; Pierce, Rockford, Ill.) according to the
procedure provided by the manufacturer. DNA concentration, as an index
of the cell number, was determined fluorometrically by using TO-PRO-1
iodide (Molecular Probes, Eugene, Oreg.). Results were compared to a
standard curve made with calf thymus DNA (Sigma).
Immunocytochemistry
For immunostainings, astrocytes were cultured on glass
coverslips. Glial fibrillary acidic protein was detected after
formaldehyde fixation, with a rabbit anti-cow GFAP (Dako, Carpinteria,
Calif.; Ref. Z-0334, dilution 1:500, 1 h incubation at room
temperature), followed by a fluorescein isothiocyanate (FITC)
-conjugated swine anti-rabbit immunoglobulin G (Dako; Ref. F-0205,
dilution 1:30, 1 h incubation at room temperature in the dark).
8-Oxo-7.8-dihydro-2'-deoxyguanosine (8-oxo-dG) was detected after
formaldehyde fixation with mouse anti-8-oxo-dG (Trevigen, Gaithersburg,
Md.; Ref. 4355-MC-100, dilution 1:100, overnight incubation at 5°C),
followed by FITC-conjugated goat anti-mouse immunoglobulin G (Dako;
Ref. F-0479, dilution 1:20, 1 h incubation at room temperature in
the dark). To differentiate between 8-hydroxyguanine formation on DNA
or RNA, the cells were treated for 1 h before immunostaining with
5 µg/µl RNase A or 1 U/µl DNase I (Roche Diagnostics Corp.,
Indianapolis, Ind.). Coloration of the nuclei was done by 15 min of
incubation with 4 µg/ml of the DNA-specific fluorochrome Hoechst
33258.
Flow cytometry
For flow cytometry experiments, astrocytes were cultured in 35
mm dishes. To prevent the problem of contact inhibition during cell
division studies, the cells were passaged after 5 days in primary
culture, at a ratio of 1 to 3, and treated for 6 h with 10 µM of
bromodeoxyuridine (BrdU; Sigma) 1 to 3 days after passage. BrdU
incorporation into the DNA was detected with FITC-conjugated mouse
anti-human BrdU (PharMingen, San Diego, Calif.; Ref. 36634K, dilution
1:5, 1 h incubation at room temperature in the dark). Analysis of
cell cycle distribution was performed using 5 µg/ml propidium iodide.
DNA oxidation was analyzed by anti-8-oxo-dG immunostaining under the
same conditions of concentration and incubation time as those used in
immunocytochemistry. All samples were run on a FACScan flow cytometer
equipped with a single 488 nm argon laser (Becton Dickinson) and 10,000
events per sample where collected.
Statistical analysis
All data obtained from 3 to 5 independent experiments are
expressed as means ± SE or medians, and for each
experiment multiple measurements were made on 3 to 6 different dishes
or wells. Statistical analyses were performed by either the Mann
Whitney nonparametric test, the paired t test, or one-way
analysis of variance, followed by the Scheffes post hoc test.
 |
RESULTS
|
|---|
Oxygen blocks MnSOD-deficient astrocyte development by reducing DNA
synthesis activity during cell division
MnSOD-deficient astrocytes in primary culture do not grow if
maintained in normoxia after initial plating. As an index of cell
number, DNA content drops to almost zero in SOD2-/-
cultures maintained in normoxia for 8 days (Fig. 1a
). In contrast, SOD2-/- cells cultured under
5% O2 develop similarly to wild-type cells. In
normoxia, SOD2-/- cells remain attached to the plates and
increase in size as demonstrated by a higher protein content 16 days
in vitro (DIV) compared to 8 DIV (Fig. 1b
).
However, protein content in SOD2-/- astrocytes cultured in
normoxia is statistically lower than in the SOD2-/-
astrocytes cultured in hypoxia and in wild-type cells. Since MnSOD
heterozygous knockout astrocytes grow to the same extent as wild-type
astrocytes in either normoxia or hypoxia, the developmental block by
oxygen is specific to cells that totally lack MnSOD.

View larger version (34K):
[in this window]
[in a new window]
|
Figure 1. Hypoxia is required for SOD2-/- astrocytes to grow in primary
culture. a, b) DNA and protein content
changes in SOD2-/-, SOD2-/+, and wild-type astrocytes. Astrocyte
cultures were maintained for 12 days under 5% O2 and
returned to normoxia (black squares, wild-type; black triangles,
SOD2-/+; black circles, SOD2-/-) or
immediately incubated under 20% O2 (white squares,
wild-type; white triangles, SOD2-/+; white circles,
SOD2-/-). DNA and protein content were measured
periodically during the entire month of the culture. *P
< 0.01 vs. wild-type maintained in normoxia. +P < 0.01
vs. SOD2-/- that remained 12 days in hypoxia.
c) Protein content in cultures maintained for increasing
period of time under 5% O2. Cultures of
SOD2-/- (black circles) and wild-type (white squares)
astrocytes were maintained for 0 to 30 days under 5% O2
and then returned to 20% O2. Protein content was measured
after 30 DIV. *P < 0.01 vs. wild-type.
+P < 0.01 vs. SOD2-/- maintained for
12 days in hypoxia. d) DNA content in cultures placed
under 5% O2 9 days after initial plating in normoxia. Nine
days after initial plating and incubation under 20% O2,
cultures of SOD2-/- (black circles) and wild-type
(white circles) astrocytes were placed under 5% O2. DNA
contents were measured periodically during the entire month of the
culture. Median values are represented by black bars for SOD2-/- and
white bars for wild-type astrocytes. *P < 0.005 vs.
each group at the initial time in hypoxia (day 9). +P <
0.005 vs. wild-type. e) LDH activity in astrocytes
maintained for increasing period of time under 5%
O2. The conditions of the culture were the same as
described for panel c (black bars,
SOD2-/-; white bars, wild-type). LDH activity was
measured after 30 DIV. *P < 0.0001 vs. LDH activity in
wild-type cells cultured only in normoxia (bar at 505.1 mU/mg).
f) Respiratory rate in SOD2-/-
and wild-type astrocytes. Respiratory rates were determined in
21-day-old cultures of SOD2-/- and wild-type
astrocytes maintained (black bars) or not (white bars) for 12 days in
hypoxia before return to normoxia using MTT as an alternative electron
acceptor. *P < 0.0001 vs. wild-type cultured only in
normoxia. +P < 0.0001 vs. SOD2-/-
maintained for 12 days in hypoxia.
|
|
SOD2-/- astrocytes do not need to be constantly
maintained in hypoxia. The first 12 to 15 days after plating are
important, and the longer the cells are kept in hypoxia during this
period of time the better they develop during the month after initial
plating (Fig. 1c
). The shorter amount of time in hypoxia
needed to obtain SOD2-/- cultures similar to wild-type
cultures corresponds to the time necessary for the cells to achieve
confluency. Maintaining SOD2-/- astrocytes in hypoxia for
a period shorter than 12 days leads to cultures with fewer cells than
normal (Fig. 2
). Without an initial hypoxic environment or a hypoxic environment
reduced to only 3 days, SOD2-/- astrocytes develop poorly
and use all of the space spared by no division, which features
hypertrophic cells (Fig. 2a
, Fig. 2b
). On the other hand, there
was no morphological difference at the age of 30 DIV between
SOD2-/- astrocytes that were maintained in hypoxia for 12
or 30 days (Fig. 2c
, 2d
).

View larger version (91K):
[in this window]
[in a new window]
|
Figure 2. Normoxic exposure leads to low density of SOD2-/- astrocytes in
primary culture featuring hypertrophic cells. Cultures of
SOD2-/- astrocytes were maintained for 0
(a), 3 (b), 12 (c), and 30
(d) days in hypoxia and returned to 20% O2.
Photomicrographs represent cells immunostained after 30 DIV with an
FITC-conjugated antibody recognizing the anti-GFAP antibody and
counterstained with Hoechst 33258 revealing the nuclei. Scale bar: 80
µm (applies to all panels).
|
|
SOD2-/- astrocytes that did not grow in normoxia
could be forced to divide by placing them in hypoxia as late as 9 days
after initial plating (Fig. 1d
). This indicates that
normoxic exposure does not irreversibly block cell development.
However, cell division remained slow and only a very small number of
plates showed an efficient salvage. Overall, there is a statistical
difference between SOD2-/- astrocytes forced to divide
after initial normoxic insult and wild-type astrocytes.
To demonstrate that the cells were halted in their division,
SOD2-/- astrocytes were incubated in normoxia and hypoxia
in the presence of BrdU for 6 h before analysis by flow cytometry.
To work with enough cells, SOD2-/- astrocytes were
initially maintained for 5 days in hypoxia, which did not suppress
oxygen toxicity as demonstrated before (see Fig. 1c
), and
then placed in normoxia. Twenty-four hours after return to normoxia,
the cells showed a slight but statistical reduction of BrdU
incorporation when compared to sister cultures maintained in hypoxia
(Fig. 3b
compared to Fig. 3a
; Table 1
). After 48 h in normoxia, the cells showed a dramatic reduction of
BrdU incorporation (Fig. 3d
compared to Fig. 3c
;
Table 1
). After 72 h in normoxia, more than half the
SOD2-/- astrocytes that would enter the S phase of the
cell cycle, if maintained in hypoxia, were repressed by oxygen toxicity
(Table 1)
. BrdU incorporation in wild-type astrocytes was similar under
5% and 20% O2, although a significant drop in
BrdU incorporation was noted the second and third day after passage
(day 1: 8.1% ± 0.3; day 2: 5.1% ± 0.3; day 3: 4.4% ± 0.2). This
decrease, which may be explained by a more rapid inhibition of contact
in wild-type astrocytes, prevented a direct comparison between these
cells and SOD2-/- astrocytes.

View larger version (40K):
[in this window]
[in a new window]
|
Figure 3. Normoxic exposure dramatically decreases BrdU incorporation into the
DNA of SOD2-/- astrocytes in primary culture. Five days after initial
plating and incubation in 5% oxygen, SOD2-/-
astrocytes were returned to normoxic conditions and treated for 6 h with 10 µM of BrdU the first or second day in normoxia. BrdU
incorporation was analyzed by flow cytometry and compared with
incorporation in cells that remained in hypoxic conditions (see Table 1
for quantitative results). BrdU positive cells are set in the upper
right quadrant. a, b) Day 1 in hypoxia
and normoxia, respectively. c and d) Day
2 in hypoxia and normoxia, respectively.
|
|
Hypoxia preconditions MnSOD-deficient astrocytes and suppresses
oxygen toxicity when the cells reenter a new cycle of cell division in
normoxia
Twelve to 15 days after plating, MnSOD-deficient astrocytes can be
removed from their hypoxic chamber and will still survive under 20%
O2 (trypan blue exclusion experiments; data not
shown). Since superoxide radicals are constantly generated by cells and
since MnSOD is a primary line of defense against superoxide radicals, a
possibility exists that the reason for MnSOD-deficient cells to survive
in normoxia is a diminution of mitochondrial activity and a stimulation
of the glycolytic pathway. A period of hypoxia longer than 8 days
stimulates LDH activity in SOD2-/- astrocytes (Fig. 1e
). This is a direct effect of hypoxia that is also
observed in wild-type astrocytes maintained for 30 days in low oxygen
concentration, and cannot be the only reason that MnSOD-deficient cells
do not suffer from oxidative injury after the return to normoxia, since
8 days in hypoxia are not enough to release the blockade of cell
division due to normoxia (see Fig. 1c
). Furthermore, no
mitochondrial activity disruption was observed by MTT staining in
SOD2-/- astrocytes that were maintained for 12 days in
hypoxia before the return to normoxia (Fig. 1f
). On the
other hand, a dramatic reduction of respiratory activity occurred in
MnSOD-deficient astrocytes that were not preserved by an initial period
of growth in hypoxia.
A modification of the antioxidant system in SOD2-/- astrocytes
initially plated under hypoxic conditions for 2 wk cannot explain the
survival of the cells under normoxia. There was no difference in
CuZnSOD, catalase and glutathione peroxidase activity between wild-type
cells and MnSOD-deficient cells (Table 2
). Only MnSOD activity was undetectable in SOD2-/-
astrocytes, as expected.
Moreover MnSOD-deficient astrocytes developed identically under 5% and
20% O2 (Fig. 4
). The rate of division of SOD2-/- astrocytes in secondary
culture was also similar to the rate of division of wild-type
astrocytes. This observation is opposite to the high degree of
sensitivity of SOD2-/- astrocytes to normoxic conditions
during initial plating and suggests that a consequence of hypoxia is to
suppress oxygen toxicity when the cells reenter a new cycle of cell
division after resting at confluency.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 4. SOD2-/- and wild-type astrocytes grow similarly in secondary culture.
Astrocyte cultures were maintained for 12 days under 5% O2
and then returned to normoxia. At the age of 21 DIV, the cells were
passaged at a ratio of 1 to 3 and cultured either in hypoxia (black
squares, wild-type; black circles, SOD2-/-) or
normoxia (white squares, wild-type; white circles,
SOD2-/-). DNA content was measured periodically for 25
days in secondary culture. *P<0.001, values
statistically different in the SOD2-/- group cultured
in normoxia, when compared within the group to the values obtained the
first day after passage. There was no statistical difference between
groups, when observed at the same age.
|
|
To further investigate the apparent adaptation of MnSOD-deficient
astrocytes to oxidative stress, we treated SOD2-/- and
wild-type astrocytes with paraquat, a superoxide radical generator.
Astrocytes showed a dose- and time-dependent sensitivity to paraquat.
Treatment with 5 mM paraquat for 15 h significantly damaged
21-day-old primary cultures of wild-type astrocytes initially
maintained for 12 days in hypoxia (Fig. 5c
compared to Fig. 5a
), but did not affect primary
cultures of SOD2-/- astrocytes (Fig. 5d
compared to 5b
). Higher doses damaged SOD2-/-
cultures, but for doses lower than 10 mM SOD2-/-
astrocytes were statistically less sensitive than wild-type astrocytes
(Fig. 6a
).

View larger version (138K):
[in this window]
[in a new window]
|
Figure 5. Paraquat at 5 mM injures wild-type but not SOD2-/- astrocytes, either
at confluence or during division in secondary culture. Astrocyte
cultures were maintained for 12 days under 5% O2 and
returned to normoxia. At the age of 21 DIV, the cells were treated with
5 mM of paraquat for 15 h or passaged at a ratio of 1 to 3 and
treated 1 day later under the same conditions. Photomicrographs in
phase contrast represent primary cultures of wild-type
(a) and SOD2-/- (b) control, wild-type
(c) and SOD2-/- (d) treated cells, and
secondary cultures of wild-type (e) and SOD2-/-
(f) control and wild-type (g) and
SOD2-/- (h) treated cells. In primary cultures, scale
bar is 200 µm; and in secondary cultures scale bar is 100 µm.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Figure 6. Hypoxia during cell development protects mature SOD2-/- astrocytes
from paraquat toxicity. Cultures of wild-type (white bars) and
SOD2-/- astrocytes (black bars) were maintained for 5
days under 5% O2 and treated for 15 h with doses of
paraquat ranging from 0 to 100 mM (dividing cells, a),
maintained for 12 days under 5% O2 and then returned to
normoxia to be treated under the same conditions, at the age of 21 DIV
(confluent cells, b), or passaged to a ratio of 1 to 3
and treated 1 day later (dividing cells in secondary culture,
c). Cellular toxicity was measured by LDH release into
the medium and expressed as a percent of maximum release that was
obtained for a dose of 100 mM of paraquat. Values statistically
different from values in the nontreated control groups
(+P<0.002), and during comparison between the wild-type
and SOD2-/- groups treated with the same doses of
paraquat (*P<0.002) are indicated.
|
|
The lower sensitivity of SOD2-/- astrocytes to paraquat
treatment was specific, in primary culture, to cells that reached
confluency after initial hypoxic growth. This was not seen in primary
cultures in division, which showed a sensitivity similar to wild-type
cultures for doses as small as 2.5 mM (Fig. 6b
). In
contrast, in secondary dividing cultures, SOD2-/-
astrocytes remained less sensitive than wild-type astrocytes to
paraquat treatment. Paraquat at 2.5 mM produced a significant release
of LDH in the medium of wild-type cells but did not lead to any
detectable increase in LDH release in SOD2-/- cells (Fig. 6c
). A dose of 5 mM dramatically destroyed wild-type
cultures but still had no statistical effect on LDH release (Fig. 6c
) or on the morphology of MnSOD-deficient cultures (Fig. 5e-h
). Stronger paraquat treatments similarly injured
SOD2-/- and wild-type cells (Fig. 6c
).
DNA oxidation is inversely correlated to the ability of
MnSOD-deficient astrocytes to divide
Since MnSOD-deficient astrocytes become insensitive to oxygen
toxicity after a prolonged period in hypoxia and since they are then
able to divide in normoxia, it was interesting to analyze the
relationship between oxidative stress and cell division. As a marker of
oxidative stress, we measured by flow cytometry and immunocytochemistry
the presence of the oxidative DNA adduct 8-oxo-dG, since guanine is the
most susceptible DNA target to a wide variety of oxidation reactions
mediated by ROS (30)
.
Five days after plating, primary cultures of wild-type and
SOD2-/- astrocytes were removed from the hypoxic chamber
and incubated in normoxia for 24 h before analysis. A
subpopulation of MnSOD-deficient cells was highly positively stained
for 8-oxo-dG compared to wild-type cells (Fig. 7a
, c
). This population was diploid as
indicated by the propidium iodide fluorescence intensity, which was
twice the intensity of the main population. By gating the cells in the
G2/S phase, it was shown that MnSOD deficiency led to a higher
oxidation of the DNA in
15% of the dividing cells (Fig. 7d
). This value is statistically different from wild-type
cells (Fig. 7b
). In contrast, SOD2-/-
astrocytes in secondary culture were stained for 8-oxo-dG to the same
extent as wild-type cells (Fig. 7e
f
g
h
), which is consistent
with their relative insensitivity to paraquat treatment.

View larger version (29K):
[in this window]
[in a new window]
|
Figure 7. DNA oxidation is higher in dividing SOD2-/- astrocytes in primary
than in secondary culture. Cultures of wild-type and
SOD2-/- astrocytes were either maintained for 5 days
under 5% O2 and returned to normoxia (primary culture) or
maintained for 12 days under 5% O2, returned to normoxia
until the age of 21 DIV and then passaged at a ratio of 1 to 3 to
induce a new cell division (secondary culture). Twenty-four hours after
return to normoxia (in the case of primary cultures) or 5 days after
passage (in the case of secondary cultures) the cells were harvested
and processed for 8-oxo-dG detection. Wild-type astrocytes in primary
culture (a, b) and in secondary culture
(e, f). SOD2-/-
astrocytes in primary culture (c,
d) and in secondary culture (g,
h). Contour plots show the total cell population.
Histograms show the repartition of 8-oxo-dG immunoreactivity inside the
groups of cells in the G2/S phase of cell division that are gated on
the upper panels (rectangles). The number of cells with high
immunoreactivity relative to the total number of cells in the G2/S
phase is indicated as percent. *P < 0.002 vs. wild-type
groups.
|
|
Immunocytochemistry showed that 8-oxo-dG staining was limited to the
cytosolic regions of the cells (Fig. 8a
). Granular staining, mainly perinuclear, suggested a
mitochondrial localization of 8-oxo-dG. Furthermore, the signal could
not be abolished by RNase treatment (Fig. 8b
), whereas it
disappeared by DNase treatment (Fig. 8c
). Microscopic
observation of 8-oxo-dG immunoreactivity remained difficult due to the
autofluorescence that masks the specific signal (Fig. 8d
).

View larger version (83K):
[in this window]
[in a new window]
|
Figure 8. 8-Oxo-dG immunoreactivity is localized in mitochondria. After initial
cell isolation and seeding on glass coverslips, cultures of
SOD2-/- astrocytes were maintained for 5 days under
5% O2 and returned to normoxia. Twenty-four hours later
the cells were fixed and processed for 8-oxo-dG immunodetection,
without further treatment (a) or after RNase A
(b) or DNase I (c) treatments.
Photographs represent cells immunostained with an FITC-conjugated
antibody recognizing the anti-8-oxo-dG antibody. d)
Cells incubated only in presence of the secondary antibody (negative
control). Scale bar: 25 µm (applies to all panels).
|
|
 |
DISCUSSION
|
|---|
The main result of this study is that astrocytes lacking the
mitochondrial form of superoxide dismutase adapted to oxygen toxicity
by a temporary stage under low O2 (5%) during
initial plating. This adaptation resulted in a higher degree of
resistance to free radical generation, as demonstrated by a lower
sensitivity to paraquat treatment, and may explain the acquired ability
of SOD2-/- astrocytes to divide under 20%
O2.
ROS have been implicated in the regulation of several physiological
processes, including cell proliferation, differentiation, apoptosis,
and senescence (9
, 31
, 32)
. Deregulation of these
processes leads to anarchic growth, characteristic of cancer cells.
Reduced MnSOD activity in certain tumor types may lead to a higher
oxidative state that favors such deregulated proliferation
(33)
. Attempts to counteract this by treatment with SOD
mimetics or by SOD gene transfer have inhibited tumor progression or
reversed the tumor phenotype (34
, 35)
. Our results show
that the blockade of cell division in SOD2-/- astrocytes
can be bypassed by a mechanism that is not a simple compensation due to
overexpression of other antioxidant enzymes. However, the cells became
less sensitive to free radical generation. Indeed, DNA oxidation, which
was higher in normoxic dividing cells in primary cultures, was not more
intense than in wild-type cells in secondary cultures. DNA oxidation
was localized in the mitochondrial compartments, which is in accordance
with a previous study performed on SOD2-/+ mice showing no
change in oxidation of cytosolic proteins or nuclear DNA
(20)
. Since the respiratory rate totally collapsed in
nonadapted SOD2-/- astrocytes and was well preserved in
adapted cells, a relationship can be suggested between energetic status
of the cells, protection against ROS, and cell division, the key
component being the new ability of the cells to counteract oxidative
stress and therefore to preserve mitochondrial functions. Recently a
quantitative correlation between the level of mitochondrial impairment
and cell respiration, cell growth, free radical production, lipid
peroxidation, mitochondrial membrane potential, and cell death was
established (36)
.
The underlying mechanisms involved in SOD2-/- astrocyte
adaptation to normoxic conditions of growth may be diverse. Transient
adaptation to oxidative stress in several mammalian cell lines involves
the de novo synthesis of at least 20 proteins, although
Northern blot and enzyme activity analyses revealed no significant
increase in transcription or translation of the classical antioxidant
enzymes (37)
. An extensive transcriptional remodeling
occurs in S. cerevisiae, which lacks a functional CuZnSOD
gene, under dioxygen stress. This remodeling results in a pattern of
expression of gene products needed for defense and repair, and
suppression of activities associated with normal cell proliferation
(38)
. Oxidative damage in eukaryotic cells can be
prevented through alterations in manganese homeostasis or in mutation
in the BSD1 (bypass SOD defects) gene (39)
.
Overexpression of Bcl-2 protects cultured lymphocytes from
oxidative death caused by either hydrogen peroxide or the redox-cycling
agent menadione (40)
and prevents neuronal death as a
result of glutathione depletion (41)
. Various biomolecules
may act as antioxidants either in the cytosol, such as pyruvate
(42)
, or at the cell membrane level, such as plasmalogens
(43)
. Therefore, our current results open the door to many
more investigations to elucidate the mechanism of adaptation of
SOD2-/- cells to oxidative stress. The progress of such
empiric studies can be boosted by the use of the newly developed gene
chips, which allow the screening of thousand of genes in one single
trial (44
, 45)
.
Independent of the understanding of the molecular mechanisms that give
unexpected competence to proliferate in an oxidative environment to
cells that lack the mitochondrial form of the superoxide dismutase and
that may provide significant insight into important problems, such as
the two-cell block of embryo development or the activity of aberrant
genes that induce cells to enter uncontrollable cycles of division, the
current results raise a fundamental question about the confidence,
sometimes too quickly developed, in experimental data generated with
mutant animals. Gene function is often studied by making irreversible
changes to the genome. This approach has a major drawback in that the
function of the gene in question must be deducted from the phenotype of
animals that are deficient in the product of the disrupted gene
throughout their development. Compensation for the loss of the gene of
interest could yield an apparently unaltered phenotype
(46)
. Alternatively, changes in the regulation of other
genes could yield a misleading phenotype. Consideration must also be
given to the genetic background of the mutant animal. The animals used
in our study were bred on a CD-1 background. The SOD2-/-
pups died within the first 10 days of life without neurological deficit
(18)
. Lebovitz et al. (17)
reported an
independently derived MnSOD null mouse on a mixed C57BL/6 and 129Sv
background with a different phenotype. The SOD2-/- pups
were able to survive up to 18 days; animals living for more than 15
days displayed neurological abnormalities, including ataxia and
seizures. By crossing MnSOD-deficient animals from different strains,
the influence of the genetic background has been clearly demonstrated
(47)
. Some of the drawbacks seen in mutations expressed
throughout ontogeny and in a systemic fashion could be circumvented if
the expression of a particular gene could be restricted both
temporarily and spatially through the use of an inducible genetic
system (48)
. This could be a good alternative to studying
the effects of MnSOD deficiency in cell culture in relation to
oxidative imbalance, since the only way so far to culture
SOD2-/- astrocytes prevents confident interpretation of
the results that can be generated because of the adaptation of the
cells and the development of an unexpected higher resistance to
oxidative stress.
Nevertheless, the model that we use needs to be further explored, since
the higher resistance developed by MnSOD-deficient astrocytes
undoubtedly is the consequence of an interaction between the lack of
MnSOD and the lower oxygenation. It may be visualized as a biphasic
oxidative stress inducer, the first phase being sublethal and the
second more intense and damaging. The cells could not resist the second
phase if they had not been, in the first place, preconditioned by a
temporary stage in hypoxia. Understanding the mechanisms leading to
those new cellular capabilities to resist to a higher level of injury
will help in understanding similar phenomena seen in ischemic
preconditioning. Indeed, it has become apparent that exposure of
tissues to brief periods of ischemia protects them from harmful effects
of subsequent, prolonged ischemia. This was first described in the
heart, but has subsequently been demonstrated in many other organs as
well as in patients with cardiovascular diseases (49
50
51)
.
In the heart, there are actually two types of protection afforded by
preconditioning, an immediate and a more delayed preconditioning.
Delayed preconditioning, or ischemic tolerance, is dependent on altered
gene expression as well as the synthesis of new proteins, including
antioxidant enzymes, heat shock proteins, and nitric oxide synthase
(52)
. Similarly, ROS may act as intracellular messengers
in a chemically induced preconditioning of the brain to ischemic injury
(53)
. The mechanisms leading to altered gene expression
and details concerning the transcription-dependent synthesis of
proteins that are associated with preconditioning are largely unknown.
Our in vitro model may become relevant in this important
field of research.
 |
ACKNOWLEDGMENTS
|
|---|
This work was supported by National Institutes of Health grants
NS14543, NS25372, NS36147, NS37530, NS38653, and NO1 NS82386. The
authors thank Jane O. Kim for breeding the animals.
Received for publication May 25, 2000.
Revision received July 17, 2000.
 |
REFERENCES
|
|---|
-
Chance, B., Sies, H., Boveris, A. (1979) Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59,527-605[Free Full Text]
-
Grisham, M. B., JourdHeuil, D., Wink, D. A. (1999) Nitric oxide I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol. 276,G315-G321[Abstract/Free Full Text]
-
Halliwell, B., Gutteridge, J. M. (1984) Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem. J. 219,1-14[Medline]
-
Kowaltowski, A. J., Vercesi, A. E. (1999) Mitochondrial damage induced by conditions of oxidative stress. Free Radic. Biol. Med. 26,463-471[Medline]
-
Ammendola, R., Fiore, F., Esposito, F., Caserta, G., Mesuraca, M., Russo, T., Cimino, F. (1995) Differentially expressed mRNAs as a consequence of oxidative stress in intact cells. FEBS Lett 371,209-213[Medline]
-
Stadtman, E. R. (1993) Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev.. Biochem. 62,797-821[Medline]
-
Yakes, F. M., Van Houten, B. (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. USA 94,514-519[Abstract/Free Full Text]
-
Sun, Y., Oberley, L. W. (1996) Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21,335-348[Medline]
-
Burdon, R. H. (1995) Superoxide and hydrogen peroxide in relation to mammalian cell proliferation Free Radic. Biol. Med. 18,775-794
-
Yu, B. P. (1994) Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74,139-162[Free Full Text]
-
van Loon, A. P., Pesold-Hurt, B., Schatz, G. (1986) A yeast mutant lacking mitochondrial manganese-superoxide dismutase is hypersensitive to oxygen. Proc. Natl. Acad. Sci. USA 83,3820-3824[Abstract/Free Full Text]
-
Guidot, D. M., McCord, J. M., Wright, R. M., Repine, J. E. (1993) Absence of electron transport (Rho 0 state) restores growth of a manganese-superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia. Evidence for electron transport as a major source of superoxide generation in vivo. J. Biol. Chem. 268,26699-26703[Abstract/Free Full Text]
-
Kong, X. J., Lee, S. L., Lanzillo, J. J., Fanburg, B. L. (1993) Cu,Zn superoxide dismutase in vascular cells: changes during cell cycling and exposure to hyperoxia. Am. J. Physiol. 264,L365-L375[Abstract/Free Full Text]
-
Johnson, M. H., Nasr-Esfahani, M. H. (1994) Radical solutions and cultural problems: could free oxygen radicals be responsible for the impaired development of preimplantation mammalian embryos in vitro?. Bioessays 16,31-38[Medline]
-
Goto, Y., Noda, Y., Narimoto, K., Umaoka, Y., Mori, T. (1992) Oxidative stress on mouse embryo development in vitro. Free Radic. Biol. Med. 13,47-53[Medline]
-
Umaoka, Y., Noda, Y., Narimoto, K., Mori, T. (1992) Effects of oxygen toxicity on early development of mouse embryos. Mol. Reprod. Dev. 31,28-33[Medline]
-
Lebovitz, R. M., Zhang, H., Vogel, H., Cartwright, J., Jr, Dionne, L., Lu, N., Huang, S., Matzuk, M. M. (1996) Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc. Natl. Acad. Sci. USA 93,9782-9787[Abstract/Free Full Text]
-
Li, Y., Huang, T.-T., Carlson, E. J., Melov, S., Ursell, P. C., Olson, J. L., Noble, L. J., Yoshimura, M. P., Berger, C., Chan, P. H., Wallace, D. C., Epstein, C. J. (1995) Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat. Genet. 11,376-381[Medline]
-
Melov, S., Coskun, P., Patel, M., Tuinstra, R., Cottrell, B., Jun, A. S., Zastawny, T. H., Dizdaroglu, M., Goodman, S. I., Huang, T.-T., Miziorko, H., Epstein, C. J., Wallace, D. C. (1999) Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc. Natl. Acad. Sci. USA 96,846-851[Abstract/Free Full Text]
-
Williams, M. D., Van Remmen, H., Conrad, C. C., Huang, T. T., Epstein, C. J., Richardson, A. (1998) Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese superoxide dismutase knockout mice. J. Biol. Chem. 273,28510-28515[Abstract/Free Full Text]
-
Murakami, K., Kondo, T., Kawase, M., Li, Y., Sato, S., Chen, S. F., Chan, P. H. (1998) Mitochondrial susceptibility to oxidative stress exacerbates cerebral infarction that follows permanent focal cerebral ischemia in mutant mice with manganese superoxide dismutase deficiency. J. Neurosci. 18,205-213[Abstract/Free Full Text]
-
Li, Y., Copin, J.-C., Reola, L. F., Calagui, B., Gobbel, G. T., Chen, S. F., Sato, S., Epstein, C. J., Chan, P. H. (1998) Reduced mitochondrial manganese-superoxide dismutase activity exacerbates glutamate toxicity in cultured mouse cortical neurons. Brain Res 814,164-170[Medline]
-
Tsan, M. F., White, J. E., Caska, B., Epstein, C. J., Lee, C. Y. (1998) Susceptibility of heterozygous MnSOD gene-knockout mice to oxygen toxicity. Am. J. Resp. Cell Mol. Biol. 19,114-120[Abstract/Free Full Text]
-
Huang, T.-T., Yasunami, M., Carlson, E. J., Gillespie, A. M., Reaume, A. G., Hoffman, E. K., Chan, P. H., Scott, R. W., Epstein, C. J. (1997) Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch. Biochem. Biophys. 344,424-432[Medline]
-
Juurlink, B. J. H., Hertz, L. (1992) Astrocytes. Boulton, B. A. Baker, G. B. Waltz, W. eds. Neuromethods ,269-321 The Humana Press Inc. Totowa, N.J..
-
Crapo, J. D., McCord, J. M., Fridovich, I. (1978) Preparation and assay of superoxide dismutases. Methods Enzymol 53,382-393[Medline]
-
Lück, H. (1965) Catalase. Bergmeyer, H. U. eds. Methods of Enzymatic Analysis ,885-891 Verlag Chemie Weinheim.
-
Paglia, D. E., Valentine, W. N. (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70,158-169[Medline]
-
Manthorpe, M., Fagnani, R., Skaper, S. D., Varon, S. (1986) An automated colorimetric microassay for neuronotropic factors. Brain Res 390,191-198[Medline]
-
Cadet, J., Delatour, T., Douki, T., Gasparutto, D., Pouget, J. P., Ravanat, J. L., Sauvaigo, S. (1999) Hydroxyl radicals and DNA base damage. Mutat. Res. 424,9-21[Medline]
-
Beckman, K. B., Ames, B. N. (1998) The free radical theory of aging matures. Physiol. Rev. 78,547-581[Abstract/Free Full Text]
-
Allen, R. G., Balin, A. K. (1989) Oxidative influence on development and differentiation: an overview of a free radical theory of development. Free Radic. Biol. Med. 6,631-661[Medline]
-
Fernandez-Pol, J. A., Hamilton, P. D., Klos, D. J. (1982) Correlation between the loss of the transformed phenotype and an increase in superoxide dismutase activity in a revertant subclone of sarcoma virus-infected mammalian cells. Cancer Res 42,609-617[Abstract/Free Full Text]
-
Church, S. L., Grant, J. W., Ridnour, L. A., Oberley, L. W., Swanson, P. E., Meltzer, P. S., Trent, J. M. (1993) Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. USA 90,3113-3117[Abstract/Free Full Text]
-
Egner, P. A., Kensler, T. W. (1985) Effects of a biomimetic superoxide dismutase on complete and multistage carcinogenesis in mouse skin. Carcinogenesis 6,1167-1172[Abstract/Free Full Text]
-
Barrientos, A., Moraes, C. T. (1999) Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 274,16188-16197[Abstract/Free Full Text]
-
Wiese, A. G., Pacifici, R. E., Davies, K. J. (1995) Transient adaptation of oxidative stress in mammalian cells. Arch. Biochem. Biophys. 318,231-240[Medline]
-
Lee, J., Romeo, A., Kosman, D. J. (1996) Transcriptional remodeling and G1 arrest in dioxygen stress in Saccharomyces cerevisiae. J. Biol. Chem. 271,24885-24893[Abstract/Free Full Text]
-
Lapinskas, P. J., Cunningham, K. W., Liu, X. F., Fink, G. R., Culotta, V. C. (1995) Mutations in PMR1 suppress oxidative damage in yeast cells lacking superoxide dismutase. Mol. Cell. Biol. 15,1382-1388[Abstract]
-
Hockenbery, D. M., Oltvai, Z. N., Yin, X. M., Milliman, C. L., Korsmeyer, S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75,241-251[Medline]
-
Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Ord, T., Bredesen, D. E. (1993) Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 262,1274-1277[Abstract/Free Full Text]
-
ODonnell-Tormey, J., Nathan, C. F., Lanks, K., DeBoer, C. J., de la Harpe, J. (1987) Secretion of pyruvate. An antioxidant defense of mammalian cells. J. Exp. Med. 165,500-514[Abstract/Free Full Text]
-
Brosche, T., Platt, D. (1998) The biological significance of plasmalogens in defense against oxidative damage. Exp. Gerontol. 33,363-369[Medline]
-
Gerhold, D., Rushmore, T., Caskey, C. T. (1999) DNA chips: promising toys have become powerful tools. Trends Biochem. Sci. 24,168-173[Medline]
-
Woychik, R. P., Klebig, M. L., Justice, M. J., Magnuson, T. R., Avner, E. D., Avrer, E. D. (1998) Functional genomics in the post-genome era. Mutat. Res. 400,3-14[Medline]
-
Bohus, B., de Wied, D. (1998) The vasopressin deficient Brattleboro rats: a natural knockout model used in the search for CNS effects of vasopressin. Prog. Brain Res. 119,555-573[Medline]
-
Huang, T. T., Carlson, E. J., Raineri, I., Gillespie, A. M., Kozy, H., Epstein, C. J. (1999) The use of transgenic and mutant mice to study oxygen free radical metabolism. Ann. N.Y. Acad. Sci. 893,95-112[Medline]
-
Gingrich, J. R., Roder, J. (1998) Inducible gene expression in the nervous system of transgenic mice. Annu. Rev.. Neurosci. 21,377-405[Medline]
-
Murry, C. E., Jennings, R. B., Reimer, K. A. (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74,1124-1136[Abstract/Free Full Text]
-
Tomai, F., Crea, F., Chiariello, L., Gioffrè, P. A. (1999) Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation 100,559-563[Abstract/Free Full Text]
-
Stagliano, N. E., Pérez-Pinzón, M. A., Moskowitz, M. A., Huang, P. L. (1999) Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 19,757-761[Medline]
-
Carden, D. L., Granger, D. N. (2000) Pathophysiology of ischaemia-reperfusion injury. J. Pathol. 190,255-266[Medline]
-
Wiegand, F., Liao, W., Busch, C., Castell, S., Knapp, F., Lindauer, U., Megow, D., Meisel, A., Redetzky, A., Ruscher, K., Trendelenburg, G., Victorov, I., Riepe, M., Diener, H. C., Dirnagl, U. (1999) Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19,1229-1237[Medline]